Since, in addition, cholesterol efflux capacity adjusted for eGFR or uromodulin was invariably associated with CVD mortality, we conclude that cholesterol efflux is not a mediator of adverse cardiovascular outcomes in renal insufficiency. The gene discussed is UMOD; the disease is Renal insufficiency.